1月

Time：2022-09-19

Authorized Beijing Union to submit an IND application to the Ministry of Health of the Russian Federation for initiating a Phase III clinical trial of azvudine for treating COVID-19 in Russia and received approval in January 2021 and commenced the Phase III clinical trial in June 2021.

Prev：3月

Next：2月